• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Nanomedicines: Design, Delivery and Detection

Nanomedicines: Design, Delivery and Detection

9781849739474
1,127.70 zł
1,014.93 zł Save 112.77 zł Tax included
Lowest price within 30 days before promotion: 1,014.93 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Nanomedicines and nanopharmacology is a rapidly developing and evolving field with new techniques and applications under constant development. This book will provide an overview of the chemistry of nanocarrier design and the considerations that need to be made when developing a nanomedicine. Providing an understanding of the relationship of nanocarrier, drug and targetting moieties and physico-chemical properties, this title will provide an accurate and current representation of the field by addressing the promises, prospects and pitfalls of nanomedicine. Covering a wide range of areas in detail, this book will provide an excellent companion for medicinal chemists, pharmacologists and biochemists working in industry or academia.
Product Details
77342
9781849739474
9781849739474

Data sheet

Publication date
2016
Issue number
1
Cover
hard cover
Pages count
370
Dimensions (mm)
156.00 x 234.00
Weight (g)
708
  • Design Considerations for Properties of Nanocarriers on the Disposition and Efficiency of Drug and Gene Delivery; Targeting Cyclins and Cyclin-Dependent Kinases Involved in Cell Cycle Regulation by RNAi as a Potential Cancer Therapy; Nanoparticle carriers to overcome biological barriers to siRNA delivery; Magnetic targeting as a vehicle for delivery of nanomedicines; Development of Theranostics - Imaging Considerations and Targeted Drug Delivery; The Role of Imaging in Nanomedicine Development and Clinical Translation; Anticancer agent-incorporating polymeric micelles:: from bench to bedside; Polymeric Nanoparticles and Cancer:: Lessons Learnt from CRLX101; Nanodelivery Strategies in Breast Cancer Chemotherapy; Developing a Predictable Regulatory Path for Nanomedicines by Accurate and Objective Particle Measurement; Nanomedicine:: Promises and Challenges; The Challenge of Regulating Nanomedicine:: Key Issues; Doxil® - The First FDA-Approved Nano-Drug:: From Basics via CMC, Cell Culture and Animal Studies to Clinical Use
Comments (0)